|
HS Code |
530818 |
| Generic Name | Ketoprofen |
| Drug Class | Nonsteroidal anti-inflammatory drug (NSAID) |
| Chemical Formula | C16H14O3 |
| Molecular Weight | 254.28 g/mol |
| Indications | Pain relief, inflammation, arthritis |
| Route Of Administration | Oral, topical, intravenous |
| Mechanism Of Action | Inhibits cyclooxygenase enzymes (COX-1 and COX-2) |
| Half Life | 2 to 4 hours |
| Common Side Effects | Gastrointestinal distress, nausea, headache |
| Contraindications | Peptic ulcer, severe heart failure, hypersensitivity to NSAIDs |
As an accredited Ketoprofen factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white plastic bottle containing 100 grams of Ketoprofen powder, labeled with product details, hazard symbols, and storage instructions. |
| Shipping | Ketoprofen is shipped as a regulated pharmaceutical or chemical product. It should be packaged in leak-proof, tightly sealed containers, protected from light and moisture. Transport must comply with local, national, and international regulations, including labeling as a prescription drug or laboratory reagent, with documentation for safe handling and emergency procedures attached. |
| Storage | Ketoprofen should be stored in a tightly closed container at room temperature, ideally between 20°C to 25°C (68°F to 77°F), away from moisture, heat, and light. It should be kept out of reach of children and separated from incompatible substances such as strong oxidizing agents. Avoid storing in bathroom cabinets or areas with fluctuating temperatures and humidity. |
Competitive Ketoprofen prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Our years of direct experience in manufacturing Ketoprofen shape how we look at this product. Every batch runs through hands-on processes, and we draw on the lessons learned from facing production hurdles head-on. The result is a consistent crystalline substance—a non-steroidal anti-inflammatory drug (NSAID) that has supported the pharmaceutical industry for decades. Unlike intermediaries who only move products from point A to point B, our focus is on perfecting fine details: maintaining API-grade purity, controlling solvent residues, and ensuring precise melting points to uphold confidence for partners who formulate finished dosages.
Ketoprofen’s full value becomes apparent in areas that can’t be glossed over by superficial marketing. The white crystalline powder owes its clinical reliability to stringent in-process monitoring and careful adjustments, should even a minor deviation emerge during synthesis. In our facility, the synthesis route follows a time-tested pathway beginning from benzoyl chloride and phenylacetic acid derivatives, but we stay alert to the variables in each stage—from condensation to cyclization and final purification. This vigilance results not only in assay values consistently surpassing 99% but also in reduced impurities: an aspect often overlooked unless you are the one striving for those certificates of analysis to pass with margin to spare.
Ketoprofen fits the IUPAC name 2-(3-benzoylphenyl)propionic acid, which may sound clinical outside the lab, but in practice, it means precision. Our typical specification targets—assay of 99.0%-101.0% (as per pharmacopoeia requirements), single impurity below 0.1%, and heavy metal content less than 10ppm—echo our commitment to transparency and predictability. Particle size matters for those pressing tablets, with d90 values routinely below 100 microns to promote uniform distribution and bioavailability. Our approach to API qualification never relies solely on minimum thresholds. Instead, we strive for documentation and traceability with each batch, ensuring clients can satisfy audits and regulatory reviews.
Physical parameters can be boring to some, but we pay attention because they predict downstream performance—melting points just above 94°C, drying loss below 0.5%, and even minor color shifts under stress that clue us in to raw material quality. The absence of persistent odor signals proper control of residual solvents, while non-hygroscopicity facilitates smoother blending in high-throughput tableting plants.
Ketoprofen shines for both acute and chronic inflammatory conditions where rapid onset and duration of activity are important. We have helped clients across geographies address varied regulatory climates, with technical support to adapt dossiers to local pharmacopoeial standards: from the USP in North America to the EP in Europe and JP in Asia. In every region, compliance is not an afterthought, but a checklist we engage with daily, aligning analytical records with ever-shifting regulatory updates.
Therapeutically, this NSAID acts by inhibiting cyclooxygenase, curbing prostaglandin synthesis to manage pain, swelling, and fever. Pharmaceutical partners formulate our Ketoprofen into tablets, gels, capsules, and injectable forms. Hospitals and pharmacies have relied on these finished products to offer quick relief in acute injury or post-operative settings as well as steady management for chronic joint pain or rheumatoid conditions. Several veterinary clients have trusted our processes to develop solutions for large and small animals. End users may never see our name, but we know our standards back the effectiveness professionals count on.
Ketoprofen shares a therapeutic territory with products such as ibuprofen and diclofenac, but differences emerge at the laboratory scale and beyond. Our scientists, who have manufactured all these molecules, note the superior analgesic speed of Ketoprofen and unique anti-inflammatory potency at lower dosages, a function of its more balanced inhibition of COX-1 and COX-2 enzymes. These distinctions inform not only clinical outcomes but also regulatory positioning and cost-effectiveness for formulation clients.
In tablet-making, the free-flowing nature of Ketoprofen reduces complications that sometimes occur with stickier competitors. We optimize crystallization parameters to enhance compressibility, cutting down on the need for excessive excipients or repeated tableting trials. That means production lines run smoother, and finished goods reach patients faster. The science behind this performance is not a matter of chance—it comes from hands-on tuning and repeated feedback from both in-house pill presses and our global formulation partners.
Industry requirements are rarely uniform, so we produce both standard and micronized forms. Some clients require a “needle” crystal habit for suspension stability, while others ask about granular forms for sustained release formulations. We listen and adapt, adjusting our final drying and milling steps. This flexibility lets research groups develop new delivery systems—topical sprays, fast-dissolve oral films, and long-acting injectables—using our Ketoprofen as a base.
Clients working in sensitive therapeutic areas or pediatric segments have prompted us to refine residual solvent and heavy metal controls even further, sometimes pushing below typical pharmacopoeial thresholds. We have responded by introducing additional purification stages and lot-specific risk assessments, informed by feedback from trial-scale productions and commercial launches alike. This cycle of inquiry and improvement means our specification sheets are living documents—updated through ongoing communication rather than one-time declarations.
Quality control keeps the whole operation honest. Each lot moves through a battery of inspections, not as a box-ticking exercise, but as a window into process strengths and improvement needs. Technicians use validated HPLC, GC, and ICP-OES methods. We have developed in-house reference standards, cross-referenced regularly against certified international materials, ensuring our results are accurate and reproducible.
Environmental responsibility is more than a slogan. About a decade ago, a production bottleneck forced us to rethink our waste solvent processing, prompting collaboration with outside engineers to design a closed-loop recovery system. This reduced both emissions and raw material consumption. Such lessons now show up in every audit file, giving downstream users assurance—not just of product quality, but of responsible stewardship throughout our plant.
Shipping pharmaceutical-grade Ketoprofen worldwide means dealing with layers of oversight and rigorous client audits. We maintain full traceability from raw material sourcing, through each synthesis and purification step, to final packing. Analytical records, third-party impurity profiles, and even shipping logs are organized to answer detailed queries from regulators and clients alike.
Decades ago, clients mainly wanted purity and assay data. Now, with changing regulations, many ask about the full impurity spectrum, nitrosamines, photostability, and extractable leachable profiles—even before placing a small pilot order. Our data archives frequently weigh in to answer such requests. We have implemented electronic batch records following 21 CFR Part 11, and our staff are trained both in production and in ensuring data integrity that stands up to healthcare authority scrutiny.
Any project in pharmaceuticals faces obstacles—delayed shipments, humidity ruining a batch, a regulatory update right before product registration. As the manufacturer, we have weathered all of these and developed responses that serve our clients well. After receiving a shipment stuck in customs, we started building flexible batch sizes and keeping validated stability data for multiple packaging formats. When an unexpected humidity spike affected suppliers in Asia, our technical team worked double shifts to supply stabilizer recommendations, sourced from our own troubleshooting database.
Formulators face unique hurdles: getting reproducible flow in high-speed tablet presses, achieving uniform dispersion in topical gels, and troubleshooting compatibility issues with other actives in combination products. Over the years, we have seen these challenges up close. Some partners struggled with low tableting yields until we shared pilot-scale compression data, highlighting the impact of subtle crystal habit changes. Other teams needed specific data on transdermal permeation to move their project forward. Because we oversee every step from kilo lab to tons, we provide real-world solutions and direct feedback—an advantage traders and brokers seldom offer.
Ketoprofen holds a reputation for broad utility in clinical settings. That reach brings added responsibility. Our ongoing investment in process safety minimizes contaminants such as residual solvents, formaldehyde, and unnamed byproducts, which could compromise downstream products. We designed analytical methods that can pick up troublesome impurities at sub-ppm levels before they become a problem.
Product accessibility extends well beyond what leaves our plant. Market demand for pain relief is global, but regulatory and economic realities differ from region to region. We have streamlined our supply logistics to reach emerging markets in Africa, Latin America, and Southeast Asia, balancing economic pressures with an uncompromising stance on pharmacopoeial compliance. Our packaging lines, for example, can fill in fiber drums with foil liners or pharmaceutical-grade double-polyethylene bags, depending on client needs and local climate, all while maintaining stability.
Manufacturing Ketoprofen rarely goes according to script. Sourcing the right phenylacetic acid derivatives can turn into a bottleneck in volatile chemical markets. We have handled supply crunches by developing dual sourcing, qualifying backup vendors, and stockpiling key intermediates when geopolitical risks rise. These practical risk mitigation efforts keep partners’ production plans on schedule. Regulatory environments also change unexpectedly—pharmacopoeial monographs update, new impurities lists emerge, and documentation demands fluctuate. We keep an eye on all of these shifts, revising protocols and records as needed.
Reproducibility under changing conditions can only happen if hands-on experience matches persistent documentation. Our batch historians know which years saw higher-than-average out-of-spec events, and why, thanks to better logging and analysis. Machine upgrades are not an annual scheduled event but a considered choice driven by recurring process data, audit reports, and front-line operator input. People see the difference this rigor makes in the field: fewer product recalls and greater credibility with regulatory inspections.
We engage with universities and contract research organizations who extend Ketoprofen’s applications into new technologies: nanocarriers, targeted delivery devices, and optimized poloxamer gels. Laboratory staff support these researchers not through generic product flyers but by providing analytical support and sharing real insight from plant-scale runs, highlighting pitfalls and opportunities in areas like solvent switch optimization or sample stability during scaling.
Start-up laboratories often approach us with “impossible” customizations: tighter impurity controls, blends with unusual excipients, or pilot lots sized for early-stage animal testing. These are not side-jobs—they are integral to scientific advancement. Our technical teams consider these trials as joint ventures, standing by to provide control samples, supply chain transparency, and speedier turnaround of technical documents.
No API remains the same as markets and science evolve. Over the years, we have phased out certain reagents for greener alternatives, reduced carbon footprint through solvent recycling systems, and worked to minimize wastewater discharge. Upgrading reactor tanks with advanced temperature sensors and automating sample tracking has paid off with higher yields and more reliable compliance reporting. Smart investments in digitalization have reduced paperwork headaches not just for us, but for every client who needs quick answers about a lot that shipped months or years ago.
Looking forward, increased demand for advanced drug delivery and patient-friendly formulations is shaping how we refine our Ketoprofen production. We have ongoing collaborations with formulation teams on solubility-enhanced API grades, modified-release profiles, and combination analgesic products where predictable particle morphology makes all the difference. Therapeutic areas such as sports injuries and veterinary pain relief continue to grow, calling for careful balancing of regulatory compliance and supply assurance.
Every statement about our Ketoprofen draws on lessons forged in active production facilities. We focus on the actual needs faced by technical managers, formulation chemists, and regulatory leads. By listening to partners and sharing direct plant-level experience, we provide more than generic assurances. Our commitment remains firmly attached to verifiable data, on-site problem-solving, and a holistic view of what makes pharmaceutical supply chains robust.
Working in chemical manufacturing blurs the lines between technical demands and practical realities. Producing Ketoprofen has taught us that sustained quality grows from skilled hands, open communication, and steady refinement—not shortcuts or off-the-shelf approaches. This philosophy guides every kilogram that leaves our gates, giving clients tangible benefits and confidence, batch after batch.